NASDAQ: AHCOAdapthealth Corp Stock
$9.58-0.20 (-2.04%)
Updated Apr 25, 2024
AHCO Price
$9.58
Fair Value Price
N/A
Market Cap
$1.27B
52 Week Low
$6.37
52 Week High
$15.37
P/E
-1.89x
P/B
0.87x
P/S
0.31x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.20B
Earnings
-$678.90M
Gross Margin
15%
Operating Margin
-18.67%
Profit Margin
-21.2%
Debt to Equity
2.09
Operating Cash Flow
$481M
Beta
0.74
Next Earnings
Jun 20, 2024
Ex-Dividend
N/A
Next Dividend
N/A
AHCO Overview
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AHCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHCO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHCO is good value based on its book value relative to its share price (0.87x), compared to the US Medical Devices industry average (3.71x)
P/B vs Industry Valuation
AHCO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AHCO due diligence checks available for Premium users.
Be the first to know about important AHCO news, forecast changes, insider trades & much more!
AHCO News
Valuation
AHCO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.89x
Industry
29.73x
Market
40.97x
AHCO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.87x
Industry
3.71x
AHCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHCO's financial health
Profit margin
Revenue
$858.2M
Net Income
-$254.5M
Profit Margin
-29.7%
AHCO's Earnings (EBIT) of -$597.60M... subscribe to Premium to read more.
Interest Coverage Financials
AHCO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.5B
Liabilities
$3.0B
Debt to equity
2.09
AHCO's short-term assets ($649.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHCO's long-term liabilities ($2.50B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHCO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AHCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$155.3M
Investing
-$90.4M
Financing
-$43.9M
AHCO's operating cash flow ($480.67M)... subscribe to Premium to read more.
Debt Coverage Financials
AHCO vs Medical Device Stocks
Adapthealth Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.